Spontaneous rupture of malignant papillary craniopharyngioma with CSF seeding and metastatic deposits: A case report and literature review.

BRAF V600K mutation Brain tumour Breast carcinoma CNS, Central Nervous System CT, Computed Tomography FLAIR, Fluid-attenuated inversion recovery GCS, Glasgow Coma Scale LP, Lumbar puncture Malignant craniopharyngioma Metastasis Papillary Spontaneous rupture

Journal

Brain & spine
ISSN: 2772-5294
Titre abrégé: Brain Spine
Pays: Netherlands
ID NLM: 9918470888906676

Informations de publication

Date de publication:
2022
Historique:
received: 16 05 2022
revised: 16 07 2022
accepted: 19 07 2022
entrez: 17 10 2022
pubmed: 18 10 2022
medline: 18 10 2022
Statut: epublish

Résumé

Craniopharyngiomas are benign tumours mainly confined to the cranial cavity in the suprasellar region. We present a rare case of an aggressive papillary craniopharyngioma with disseminated spinal intradural disease. A 67-year-old woman presented with a 4-month history of headache, visual disturbance, acute confusion and radicular leg pain. Previous history of breast carcinoma (ER ​+ ​PR ​+ ​HER2-) was noted. The importance of histological diagnosis prior to treatment of sellar or suprasellar lesions with atypical or aggressive features is explored. MRI demonstrated a partly solid and partly cystic pituitary mass lesion in the sellar and suprasellar region with chiasmal compression and hypothalamic involvement. The sella was mildly enlarged and there were no calcifications. Whole neuraxis MRI revealed intradural deposits involving the ventricular system, spinal cord and conus. Within a month, the lesion rapidly increased in size. The patient underwent a craniotomy and transventricular resection of the sellar and suprasellar mass. Cranial lesion histology favoured papillary craniopharyngioma, confirmed by BRAF V600 mutation. Lumbar puncture CSF cytology confirmed craniopharyngioma with BRAF mutation and no evidence of metastatic breast cancer. The patient remained confused postoperatively without focal neurological deficit and underwent palliative whole brain radiotherapy. She died 4 months later. A review of the literature identified 29 reports of ruptured craniopharyngioma. Ruptured craniopharyngioma presents with a suprasellar mass and drop lesions in the spinal canal, characteristics radiologically indistinguishable from metastatic disease. The importance of histological diagnoses in directing the management of these cases is highlighted.

Identifiants

pubmed: 36248177
doi: 10.1016/j.bas.2022.100921
pii: S2772-5294(22)00062-5
pmc: PMC9560665
doi:

Types de publication

Case Reports

Langues

eng

Pagination

100921

Informations de copyright

Crown Copyright © 2022 Published by Elsevier B.V. on behalf of EUROSPINE, the Spine Society of Europe, EANS, the European Association of Neurosurgical Societies.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Neuro Oncol. 2012 Aug;14(8):1070-8
pubmed: 22735773
Neurol Med Chir (Tokyo). 1984 Dec;24(12):954-7
pubmed: 6085143
J Neurol Neurosurg Psychiatry. 1989 Jun;52(6):803-4
pubmed: 2746279
J Neurol Neurosurg Psychiatry. 1961 Feb;24:1-13
pubmed: 13744863
Int J Crit Illn Inj Sci. 2017 Apr-Jun;7(2):126-128
pubmed: 28660168
Oncogene. 2003 Jul 24;22(30):4757-9
pubmed: 12879021
Drugs Context. 2019 Mar 13;8:212566
pubmed: 30899313
Am J Med. 1988 Mar;84(3 Pt 1):543-5
pubmed: 3348255
Cancer. 1987 Sep 1;60(5):1077-80
pubmed: 3300946
Neurol Med Chir (Tokyo). 1998 Oct;38(10):666-8
pubmed: 9861852
Pituitary. 2007;10(1):103-6
pubmed: 17318439
J Clin Neurosci. 2008 May;15(5):603-6
pubmed: 18329880
No To Shinkei. 2001 Oct;53(10):957-60
pubmed: 11725506
Neurol Med Chir (Tokyo). 2015;55(1):89-94
pubmed: 24670310
J R Soc Med. 2004 Dec;97(12):585-6
pubmed: 15574858
Rinsho Shinkeigaku. 1976 Sep;16(9):607-16
pubmed: 1034544
Am J Surg Pathol. 2007 Jul;31(7):1020-8
pubmed: 17592268
J Neurosurg. 1985 Jan;62(1):132-4
pubmed: 3964844
Endocr Rev. 2006 Jun;27(4):371-97
pubmed: 16543382
N Engl J Med. 1997 Jun 26;336(26):1895-903
pubmed: 9197219
Acta Neurochir (Wien). 2018 Jun;160(6):1203-1206
pubmed: 29663082
J Neurol Surg Rep. 2016 Oct;77(4):e151-e155
pubmed: 27722072
Front Endocrinol (Lausanne). 2012 Mar 29;3:46
pubmed: 22654868
Nervenarzt. 1964 Jan;35:42-4
pubmed: 14158745
Neurol Med Chir (Tokyo). 2003 Mar;43(3):150-2
pubmed: 12699125
J Neurosurg. 1974 Sep;41(3):387-90
pubmed: 4412094
Surg Neurol. 1993 Nov;40(5):414-9
pubmed: 8211660
Postgrad Med J. 1977 Feb;53(616):82-5
pubmed: 876925
Surg Neurol. 2000 Sep;54(3):249-53: discussion 253
pubmed: 11118572

Auteurs

Asfand Baig Mirza (A)

Skull Base Unit, Department of Neurosurgery, King's College Hospital NHS Foundation Trust, London, UK.

Melika Akhbari (M)

GKT School of Medical Education, King's College London, London, UK.

Christopher Murphy (C)

Skull Base Unit, Department of Neurosurgery, King's College Hospital NHS Foundation Trust, London, UK.

Steve Connor (S)

Department of Clinical Neuroradiology, King's College Hospital NHS Foundation Trust, London, UK.

Mark R Howard (MR)

Department of Histopathology, King's College Hospital NHS Foundation Trust, London, UK.

Zita Reisz (Z)

Department of Clinical Neuropathology, King's College Hospital NHS Foundation Trust, London, UK.

Sinan Barazi (S)

Skull Base Unit, Department of Neurosurgery, King's College Hospital NHS Foundation Trust, London, UK.

Nick Thomas (N)

Skull Base Unit, Department of Neurosurgery, King's College Hospital NHS Foundation Trust, London, UK.

Istvan Bodi (I)

Department of Clinical Neuropathology, King's College Hospital NHS Foundation Trust, London, UK.

Eleni C Maratos (EC)

Skull Base Unit, Department of Neurosurgery, King's College Hospital NHS Foundation Trust, London, UK.

Classifications MeSH